| Literature DB >> 25660532 |
Katharina B Mohr1, Onofrio Zirafi2, Mark Hennies3, Sebastian Wiese4, Frank Kirchhoff5, Jan Münch6.
Abstract
Urinary levels of human serum albumin (hSA) fragment 408-423 have been proposed to represent an early marker for graft-versus-host disease (GvHD) and chronic kidney diseases. Here, we developed an enzyme-linked immunosorbent assay (ELISA) for the quantification of hSA(408-423). The sandwich ELISA has a detection limit of 0.5ng/ml and is highly specific for hSA(408-423) because it does not cross-react with other albumin fragments or the full-length precursor. This ELISA allows rapid and convenient quantification of hSA(408-423) in bodily fluids, further clarifying the prognostic and diagnostic value of this peptide in GvHD, kidney disease, and other disorders.Entities:
Keywords: Biomarker; ELISA; Graft-versus-host disease; Human serum albumin; Kidney disease; Peptide
Mesh:
Substances:
Year: 2015 PMID: 25660532 DOI: 10.1016/j.ab.2015.01.023
Source DB: PubMed Journal: Anal Biochem ISSN: 0003-2697 Impact factor: 3.365